Józef Kozak Selected Research

EDDA (NiEDDA)

9/2006	Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: the effect of tumour size on the optimal method of image assessment.
2/2006	Short communication: Semiquantitative assessment of 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules--a complementary role to visual analysis.
1/2006	Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
10/2004	Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules.
7/2004	99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.
1/2004	A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Józef Kozak Research Topics

Disease

7	Neoplasms (Cancer) 10/2020 - 02/2006
6	Solitary Pulmonary Nodule 09/2006 - 01/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 02/2018
2	Pathologic Constriction (Stenosis) 01/2016 - 06/2014
2	Neoplasm Metastasis (Metastasis) 01/2006 - 10/2003
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Pneumothorax 10/2019
1	Hematoma 10/2019
1	Adenocarcinoma of Lung 05/2019
1	Fistula 01/2016
1	Deglutition Disorders (Dysphagia) 01/2016
1	Esophageal Neoplasms (Esophageal Cancer) 01/2016
1	Pleural Diseases 12/2014
1	Cysts 09/2014
1	Lacerations 06/2014
1	Wounds and Injuries (Trauma) 03/2014
1	Peritoneal Fibrosis 01/2013
1	Carcinoma (Carcinomatosis) 07/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2003
1	Carcinoid Tumor (Carcinoid) 10/2003
1	Prostatic Neoplasms (Prostate Cancer) 10/2003
1	Melanoma (Melanoma, Malignant) 10/2003
1	Leiomyosarcoma 10/2003

Drug/Important Bio-Agent (IBA)

6	EDDA (NiEDDA)IBA 09/2006 - 01/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2018
2	RadiopharmaceuticalsIBA 02/2006 - 01/2006
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2004 - 07/2004
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	MicroRNAs (MicroRNA)IBA 02/2018
1	Ethanol (Ethyl Alcohol)IBA 09/2014
1	Tamoxifen FDA LinkGeneric 01/2013
1	AnticoagulantsIBA 07/2007
1	99mTc-octreotideIBA 01/2006
1	Radioisotopes (Radionuclides)IBA 01/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2006
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2003

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2016
2	Stents 01/2016 - 06/2014
2	Thoracotomy 03/2014 - 07/2007
1	Catheters 10/2019
1	Esophagectomy 12/2016
1	Adjuvant Chemoradiotherapy 09/2016
1	Palliative Care (Palliative Therapy) 01/2016
1	Prostheses and Implants (Prosthesis) 01/2016
1	Pneumonectomy (Lung Volume Reduction) 12/2014
1	Sternotomy 03/2014
1	Kidney Transplantation 01/2013